9.3 Phlebotomy and Lab Testing Simulation Lab
Key Takeaways
- Follow the CLSI order of draw - blood culture, light blue, then serum, green, lavender, gray - to prevent additive carryover.
- Label every tube at the bedside in the patient's presence; an unlabeled specimen usually requires recollection.
- Do not run patient samples on CLIA-waived devices until quality control is in range.
Why This Lab Matters
Phlebotomy and point-of-care testing sit inside Clinical Patient Care, and the NHA writes them around three failure modes: wrong patient, wrong or contaminated specimen, and invalid result. Many items test the order of draw and specimen integrity, where a single misstep silently corrupts results.
CLSI Order of Draw
The Clinical and Laboratory Standards Institute order prevents additive carryover between tubes. Memorize the sequence and the additive:
| Order | Tube top color | Additive | Common tests |
|---|---|---|---|
| 1 | Yellow / blood culture | SPS | Sterile cultures |
| 2 | Light blue | Sodium citrate | PT, PTT, INR (coagulation) |
| 3 | Red / gold (SST) | None / clot activator | Serum chemistry |
| 4 | Green | Heparin | Plasma chemistry |
| 5 | Lavender | EDTA | CBC, hematology |
| 6 | Gray | Sodium fluoride | Glucose, lactate |
The light blue (citrate) tube is critical: it must be filled to the line for a correct 9:1 blood-to-anticoagulant ratio. An underfilled blue tube falsely prolongs clotting results and must be redrawn.
Capillary Collection
For a fingerstick, use the side of the middle or ring fingertip, wipe away the first drop, and avoid aggressive squeezing ("milking"), which dilutes the sample with interstitial tissue fluid and falsely changes results. For an infant heel stick, use only the medial or lateral plantar surface to avoid bone. The capillary order of draw differs: collect EDTA (lavender) first, then other additives, then serum.
Labeling and Specimen Integrity
Label each tube immediately after collection, at the bedside, in the patient's presence, with two identifiers, plus date, time, and collector initials. An unlabeled or mislabeled tube breaks the chain of identity and, per most policies and CLIA rules, requires recollection - never relabeling from memory. Reject criteria you should recognize: hemolysis (falsely elevates potassium), clotted EDTA tubes, underfilled coagulation tubes, and specimens past stability or transport time.
CLIA-Waived Testing and Quality Control
CLIA-waived tests (rapid strep, urine dipstick, glucose meter, pregnancy, A1c, lipid panels) are simple but still require quality control. Run external controls per manufacturer and policy; if a QC value is out of range, you may not test patients until the problem is resolved (new strips, recalibration, fresh control). You never average a failed QC or report patient values as normal to keep moving.
Worked Scenario
A light blue tube comes back from the analyzer flagged "short draw." The tempting choice is to run it anyway since blood was obtained. The correct action is to recognize the citrate ratio is wrong and redraw, because an underfilled coagulation tube produces falsely prolonged PT/PTT results that could trigger inappropriate treatment.
Common Traps
- Labeling tubes later at the desk instead of at the bedside.
- Drawing the lavender tube before the light blue in a venous multi-tube draw.
- Running patient samples after a failed control.
- Vigorous finger milking during a capillary stick.
Remediation Method for This Lab
When you miss a lab item, rewrite the rule as a fixed sequence or threshold ("blue before red," "QC out of range = stop patient testing," "unlabeled tube = recollect"). Drill it in a mixed timed set so order-of-draw recall and the safe-action judgment travel together. Mark the topic repaired only when you can recite the affected additive, the consequence of the error, and the required corrective step.
Site Selection and Venipuncture Safety
The preferred venipuncture site is the antecubital fossa, where the median cubital vein is the first choice because it is large, well-anchored, and sits away from major nerves and the brachial artery. Avoid drawing from an arm with a fistula, an active mastectomy side, an IV line above the puncture, extensive scarring, or a hematoma. The tourniquet stays on no longer than one minute, because prolonged constriction causes hemoconcentration that falsely raises analytes such as potassium and protein. Insert the needle bevel up at roughly a 15-30 degree angle.
If the patient feels shooting pain or you see arterial pulsation, stop immediately - those signal nerve or artery involvement.
Recognizing and Preventing Hemolysis
Hemolysis - ruptured red cells releasing their contents into the serum - is a leading cause of rejected specimens, and the exam tests both its causes and its consequences. Causes include using a needle that is too small, drawing too forcefully, vigorous shaking instead of gentle inversion, frothing at the draw, and forcing blood from a syringe through the needle. The most clinically important consequence is a falsely elevated potassium, which can mimic a dangerous hyperkalemia and trigger unnecessary intervention.
Prevent it by inverting additive tubes gently the correct number of times, allowing the tube to fill by vacuum, and using an appropriately sized needle.
Specimen Handling and Transport
After collection, many tests have time and temperature requirements. Glucose in a gray (sodium fluoride) tube is stabilized against glycolysis, but a serum glucose left uncentrifuged drops over time. Light-sensitive analytes such as bilirubin require an amber container. Some specimens must be chilled or kept warm during transport, and a delay past the stability window is a rejection criterion just like an unlabeled tube. When a scenario describes a delayed, mishandled, or improperly stored specimen, the safe answer protects result integrity - recollect or follow the handling protocol rather than report a questionable value.
A collected blood tube is found unlabeled after the patient has left. What is the safest response?
In the CLSI venous order of draw, which tube is collected before serum (red/SST) tubes?
A glucose meter quality-control result is out of range. What should the CCMA do?
Why is aggressive finger squeezing discouraged during a capillary collection?